Literature DB >> 19551370

Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit.

Anne Marie G A de Smet1, Titia E M Hopmans, Albertus L C Minderhoud, Hetty E M Blok, Annelies Gossink-Franssen, Alexandra T Bernards, Marc J M Bonten.   

Abstract

OBJECTIVE: To determine the incidence rates of hospital acquired infections (HAI) during the first 14 days after ICU discharge after treatment during ICU-stay with Selective Decontamination of the Digestive tract (SDD), Selective Oropharyngeal Decontamination (SOD) or Standard Care (SC).
DESIGN: Prospective observational study.
SETTING: ICUs in two tertiary care hospitals. PATIENTS: Patients discharged from the ICU to the ward.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Post-ICU incidences of HAI per 1,000 days at risk were 11.2, 12.9 and 8.3 for patients that had received SDD (n = 296), SOD (n = 286) or SC (n = 289) respectively in ICU, yielding relative risks, as compared to SC, of 1.49 (CI(95) 0.9-2.47) for SOD and 1.44 (CI(95) 0.87-2.39) for SDD. Incidences of surgical site infections (per 100 surgical procedures) were 4 after SC and 11.8 and 8 after SOD and SDD (p = 0.04). Among patients that succumbed in the hospital after ICU-stay (n = 58) eight (14%) had developed HAI after ICU discharge; 3 of 21 after SDD, 3 of 15 after SOD and 2 of 22 after SC.
CONCLUSIONS: Incidences of HAI in general wards tended to be higher in patients that had received either SDD or SOD during ICU-stay, but it seems unlikely that these infections have an effect on hospital mortality rates.

Entities:  

Mesh:

Year:  2009        PMID: 19551370      PMCID: PMC2726913          DOI: 10.1007/s00134-009-1554-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


Introduction

Prophylactic antibiotic regimens, such as Selective Decontamination of the Digestive tract (SDD) and Selective Oropharyngeal Decontamination (SOD), reduce the incidence of respiratory tract infections (RTI) in Intensive Care Unit (ICU) patients and improve survival [1-6]. The concept of SDD, developed in the 1980s [7, 8] consists of prevention of secondary colonization with Gram negative bacteria, S. aureus, and yeasts through application of non-absorbable antimicrobial agents in the oropharynx and gastrointestinal tract. Further it consists of pre-emptive treatment of possible infections due to commensal respiratory tract bacteria through systemic administration of cephalosporins during the first four days in ICU and maintaining the anaerobic intestinal flora through the use of antibiotics (both topically and systemically) not active against anaerobic bacteria [8]. In meta-analyses, three single center randomized studies and a recent multi-center trial, SDD was associated with improved patient survival [1, 4, 6, 9–11]. SOD (application of topical antibiotics in the oropharynx only) might be an alternative to SDD, as they are both effective in reducing day 28 mortality in a recent multi-center study [6]. SDD (and to lesser extent SOD) aim to extensively modulate the microbial ecology of patients. It is unknown how discontinuation of these interventions at ICU discharge changes the patients’ microbial ecology and whether this influences their immediate risk of infections. The current study was motivated by the findings from de Jonge et al. [4]. In their SDD study the observed relative risk reduction (RRR) in ICU mortality of 35% reduced to 22% at hospital discharge. This reduction in survival benefit after ICU discharge might have been related to an increased incidence of hospital acquired infection (HAI) in those patients that had received SDD in ICU. Nested within a multi-center SDD–SOD trial we prospectively monitored the occurrence of HAI during the first 14 days after ICU discharge in all patients transferred to regular wards in two university hospitals.

Patients and methods

Setting

The study was conducted in two tertiary care hospitals: the University Medical Center Utrecht and the Leiden University Medical Center. Nested within a multi-center SDD–SOD trial [6], the occurrence of HAI during the first 14 days after ICU discharge was prospectively monitored in all patients transferred to regular wards.

Study design, data collection and definitions

In ICU, patients with an expected stay ≥72 h, or with an expected duration of mechanical ventilation ≥48 h, had received either SDD, SOD or standard care (SC), which rotated in 6-month periods, as described previously [6]. Data were collected from patient records for a maximum of 14 days post-ICU. The following data were recorded for each patient: gender, age, length of stay at the ICU, mechanical ventilation and APACHE II score at the ICU. At the wards, medical records were prospectively reviewed twice weekly by an Infection Control Professional for HAI according to the Centers for Disease Control and Prevention (CDC) definitions [12, 13]. In the surveillance period the following HAIs (and day of diagnosis) were registered in both hospitals: surgical site infections (SSI), bloodstream infections (BSI), and RTI. In one of the hospitals, oropharyngeal infections were also registered. Infection control policies (other than the subject of the study) did not change during the period of the study in either hospital.

Data analysis

The incidence of HAI was expressed per 1,000 days at risk, i.e. days until first HAI, day of discharge or end of observation period. The proportion of patients with HAI was expressed as the total number of patients with HAI per 100 patients surveyed post-ICU, with 95%-confidence interval (CI95). The total number of SSIs was expressed per 100 patients with surgical procedures. Statistical analysis was performed with SPSS for Windows 12.0.1 (SPSS, Inc., Chicago, IL, USA). Differences in continuous variables between groups were determined by Student’s t test. Differences in proportions of HAI (with CI95) in the successive study periods were determined. Statistical significance was defined as a p value of less than 0.05.

Results

Patients

Between May 2004 and July 2006, 871 patients were included; 289 after SC, 286 after SOD and 296 SDD (Fig. 1). Reasons for patients being lost to follow-up (n = 122) mainly included their transfer to other hospitals after ICU discharge. Although fewer patients in the SC group had received mechanical ventilation in ICU (84% vs. 96% and 94% in SOD and SDD, respectively), other characteristics (such as age, sex, Apache II-score on ICU admission and surgical or non-surgical reasons for admission) were comparable for all three groups (Table 1).
Fig. 1

Flowchart

Table 1

Patients’ characteristics

Standard careSODSDD
No. of patients289286296
Sex (male/female)187/102181/105180/116
Age
 Mean (median)56.7 (59)57.9 (61)57.0 (60)
 SD1817.117.5
 Range16–9312–8716–87
APACHE II at ICU admission
 Mean (median)18.9 (18)19.8 (19)20.1 (19)
 SD7.857.867.98
 Range4–484–450–45
LOS in ICU
 Mean (median)13.6 (8)12.6 (8)14.2 (9)
 SD1511.815.1
 Range1–1411–931–121
Mechanical ventilation in ICU
 Yes (%)243 (84)*274 (96)*279 (94)*
 No461217
Specialty
 Cardiology91510
 Cardiothoracic surgery132716
 Surgery10994117
 Medical615461
 Pulmonology887
 Neurosurgery384943
 Neurology282623
 Other231319
No. of surgical patients126127137

LOS Length of stay

* Standard care versus SOD and SDD significantly different (p = 0.000), no difference between SOD and SDD

Flowchart Patients’ characteristics LOS Length of stay * Standard care versus SOD and SDD significantly different (p = 0.000), no difference between SOD and SDD

End points

The numbers of patients with HAI were 23, 34 and 34 from the SC, SOD and SDD groups, respectively, yielding incidences per 1,000 days at risk of 8.3, 12.9 and 11.2 for SC, SOD and SDD, respectively (Table 2). As compared to SC, the relative risks for developing HAI in the first 14 days after ICU discharge were 1.49 (CI95 0.9–2.47) after SOD and 1.44 (CI95 0.87–2.39) after SDD. Oropharyngeal infections, only registered in one hospital, occurred in one patient after SC and in four patients after SOD.
Table 2

Infections, time until diagnosis and mortality

Standard care (N = 289)SOD (N = 286)SDD (N = 296)
Number of patients with HAI233434
Number of HAI263937
Incidence of HAI/1,000 days at risk8.312.911.2
RR standard care versus intervention1.491.44
CI950.9–2.470.87–2.39
Proportion of patients (%)with HAI81211
CI955–128–168–16
Specialty of patients with HAI
 Cardiology12
 Cardiothoracic surgery2
 Surgery121419
 Medical274
 Pulmonology
 Neurosurgery336
 Neurology243
 Other322
Mortality: no. of patients (%)22 (7.6)15 (5.2)21 (7.1)
Mortality of patients with HAI: no. of patients (%)2 (8.7)3 (8.8)3 (8.8)
Mean LOS in surveillance on ward (days)10.110.011.0
Median; range13; 1–1414; 1–1414; 1–14
No. of RTI161818
Mean time until diagnosis (days)4.65.04.7
Median; range4.5; 1–94.5; 1–133.5; 1–12
No. of BSI558
Mean time until diagnosis (days)4.85.69.0
Median; range4.0; 1–85; 2–1210; 1–12
No. of SSI51511
Incidence/100 surgical procedures4.011.88.0

Differences in times until diagnosis are not significant between the three groups or between the standard care group versus SOD and SDD combined

HAI Hospital acquired infections, RR relative risk, LOS length of stay, RTI respiratory tract infection, BSI blood stream infection, SSI surgical site infection

The proportion of patients with HAI in the standard care period versus SOD and SDD combined (RR 1.47, CI95 0.935–2.305) is not significantly different

Infections, time until diagnosis and mortality Differences in times until diagnosis are not significant between the three groups or between the standard care group versus SOD and SDD combined HAI Hospital acquired infections, RR relative risk, LOS length of stay, RTI respiratory tract infection, BSI blood stream infection, SSI surgical site infection The proportion of patients with HAI in the standard care period versus SOD and SDD combined (RR 1.47, CI95 0.935–2.305) is not significantly different Most infections were RTI, with similar incidences and similar time until diagnosis in all three study groups (Table 2). Adjustment for the difference in number of mechanically ventilated patients in ICU did not change these observations. Incidences of BSI were also similar between the three groups, but the duration until infection tended to be longer in the post-intervention groups (means of 4.8 for SC and 7.7 days for SOD and SDD combined, p = 0.17 when comparing SC to SDD and SOD combined). Incidences of SSI, expressed per 100 surgical procedures were 4 after SC, as compared to 11.8 after SOD and 8 after SDD (p = 0.04 when comparing SC to SDD and SOD combined). Among the 26 patients with SSI in both post-intervention groups, 18 were diagnosed with superficial infections (15 patients not cultured or with a negative culture) and in 7 patients Staphylococcus aureus was documented as the cause of SSI. Hospital mortality was 7.6% (22 patients) in the SC group, 5.2% (15 patients) in the SOD group and 7.1% (21 patients) in the SDD group. Hospital mortality among patients that developed HAI was 8.7% (n = 2), 8.8% (n = 3) and 8.8% (n = 3).

Discussion

Incidences of HAI in general wards tended to be higher in patients that had received either SDD or SOD during ICU-stay, but it seems unlikely that these infections have an important effect on hospital mortality rates. Of note, the observed differences in relative risks only approached statistical significance. To the best of our knowledge this is the first study that has quantified timing and incidences of infections in general wards after ICU discharge related to antimicrobial infection prevention measures in the ICU. Strengths include the prospective monitoring of infections performed by a limited number (n = 3) of trained and experienced infection control professionals. The open study design in the ICU was an unavoidable limitation of the present analysis. By using objective, and internationally accepted, criteria we aimed to minimize information bias. The fact that the study was performed in only two tertiary care centers may reduce the generalizability of our findings. The observed tendency towards a higher infection rate after an antibiotic intervention in ICU might be related to differences in patient risk factors or to changes in the colonization status between the intervention groups and the patients that received standard care. Indeed, at the time of ICU admission, a higher proportion of patients in the standard group did not receive mechanical ventilation. Yet, there were no significant differences in age, APACHE II score at the time of ICU admission or the lengths of stay in ICU or on mechanical ventilation, or in distribution of medial specialties. We therefore assume that the risk profile at the time of ICU discharge was similar for the three patient populations. Both SDD and SOD aim to modulate the colonization status of patients, which resulted in lower colonization rates with Gram negative bacteria in the respiratory and intestinal tract [6]. After discontinuation of the prophylactic regimens, though, patients may acquire colonization with typical hospital pathogens or suppressed colonization with such bacteria may reemerge. If these phenomena are relevant, and whether they are responsible for our observations, remains to be determined. Our study was motivated by the observation of a tendency towards higher mortality rates after ICU discharge among patients that had received SDD in a previous study [4]. In the current study, 58 patients (7%) succumbed in the hospital after ICU discharge, and eight (14%) of these patients had been diagnosed with a HAI in the first 14 days after ICU discharge. Overall mortality rates were comparable between the three study groups and the numbers of patients that died after developing a HAI was two in the standard care period and three in both the SDD and SOD period. Considering the low rates of infection, the overall low mortality rates after ICU discharge and the low prevalence of infections among those that succumbed after ICU discharge, we reject the hypothesis that an increased infection rate after ICU discharge affects the clinical outcome of patients that have received SDD or SOD in ICU, in spite of a tendency of more infections, especially superficial SSIs, in these patients after ICU discharge.
  13 in total

1.  Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  D C Bergmans; M J Bonten; C A Gaillard; J C Paling; S van der Geest; F H van Tiel; A J Beysens; P W de Leeuw; E E Stobberingh
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

2.  Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial.

Authors:  Wolfgang A Krueger; Franz-Peter Lenhart; Gertraud Neeser; Gotthart Ruckdeschel; Heidi Schreckhase; Hans-Joachim Eissner; Helmuth Forst; Joachim Eckart; Klaus Peter; Klaus E Unertl
Journal:  Am J Respir Crit Care Med       Date:  2002-10-15       Impact factor: 21.405

3.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.

Authors:  T C Horan; R P Gaynes; W J Martone; W R Jarvis; T G Emori
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

4.  Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials.

Authors:  R D'Amico; S Pifferi; C Leonetti; V Torri; A Tinazzi; A Liberati
Journal:  BMJ       Date:  1998-04-25

5.  Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial.

Authors:  Miguel A de La Cal; Enrique Cerdá; Paloma García-Hierro; Hendrick K F van Saene; Dulce Gómez-Santos; Eva Negro; José Angel Lorente
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

6.  The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients.

Authors:  C P Stoutenbeek; H K van Saene; D R Miranda; D F Zandstra
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

7.  Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1971-09

8.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

Review 9.  Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence.

Authors:  A B Nathens; J C Marshall
Journal:  Arch Surg       Date:  1999-02

10.  Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial.

Authors:  Evert de Jonge; Marcus J Schultz; Lodewijk Spanjaard; Patrick M M Bossuyt; Margaretha B Vroom; Jacob Dankert; Jozef Kesecioglu
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

View more
  8 in total

1.  Characterization of Enterobacter cloacae pneumonia: a single-center retrospective analysis.

Authors:  Jan K Hennigs; Hans Jörg Baumann; Stefan Schmiedel; Pierre Tennstedt; Ingo Sobottka; Carsten Bokemeyer; Stefan Kluge; Hans Klose
Journal:  Lung       Date:  2011-10-19       Impact factor: 2.584

Review 2.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

3.  Top stories of 2009.

Authors:  S K Todi
Journal:  Indian J Crit Care Med       Date:  2010-01

Review 4.  Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-08       Impact factor: 17.440

5.  Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.

Authors:  Elena Buelow; Teresita D J Bello González; Susana Fuentes; Wouter A A de Steenhuijsen Piters; Leo Lahti; Jumamurat R Bayjanov; Eline A M Majoor; Johanna C Braat; Maaike S M van Mourik; Evelien A N Oostdijk; Rob J L Willems; Marc J M Bonten; Mark W J van Passel; Hauke Smidt; Willem van Schaik
Journal:  Microbiome       Date:  2017-08-14       Impact factor: 14.650

6.  Structural equation modeling the "control of gut overgrowth" in the prevention of ICU-acquired Gram-negative infection.

Authors:  James C Hurley
Journal:  Crit Care       Date:  2020-05-04       Impact factor: 9.097

7.  Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series.

Authors:  Lucas H P Bernts; Shosha E I Dekker; Darius Soonawala; Roger J M Brüggemann; Heiman F L Wertheim; Johan W de Fijter; Joost P H Drenth; Marten A Lantinga
Journal:  J Antimicrob Chemother       Date:  2020-09-01       Impact factor: 5.790

Review 8.  What is new in selective decontamination of the digestive tract?

Authors:  Jozef Kesecioglu; Philippe Eggimann
Journal:  Intensive Care Med       Date:  2015-08-18       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.